Author:
Nati Marina,Haddad David,Birkenfeld Andreas L.,Koch Christian A.,Chavakis Triantafyllos,Chatzigeorgiou Antonios
Funder
European Research Council
Else Kröner-Fresenius-Stiftung
TU- Dresden Medical Faculty
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference165 articles.
1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43(2 Suppl 1):S99–112.
2. Berlanga A, Guiu-Jurado E. Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol. 2014;7(1):221–39.
3. Wong VW, Wong GL, Choi PC, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut. 2010;59(7):969–74.
4. Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482(7384):179–85.
5. Tang T, Sui Y, Lian M, Li Z, Hua J. Pro-inflammatory activated kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death. PLoS ONE. 2013;8(12):e81949.